Cinclus Pharma Holding AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	475.85	487.25	566.72	87.97	173.55	138.2
Cash & Short-Term Investments	475.85	487.25	566.72	87.97	173.55	138.2
Cash Growth	-9.17%	-14.02%	544.20%	-49.31%	25.57%	-33.72%
Accounts Receivable	1.42	16.06	4.58	-	-	-
Other Receivables	4.06	5.9	2.93	3.98	10.23	1.38
Receivables	5.48	21.96	7.51	3.98	10.23	1.38
Prepaid Expenses	21.46	2.2	1.23	2.14	1.11	0.39
Other Current Assets	-	25.44	25.02	-	-	5.38
Total Current Assets	502.79	536.85	600.47	94.09	184.88	145.36
Property, Plant & Equipment	8.56	9.41	0.54	0.32	0.89	1.82
Other Long-Term Assets	0.3	0.3	0	0	0	0
Total Assets	511.64	546.56	601.01	94.41	185.77	147.18
Accounts Payable	29.52	48.46	18.93	16.45	16.95	9.19
Accrued Expenses	23.21	20.83	16.9	6.83	20.47	7.51
Short-Term Debt	-	-	-	131.01	-	-
Current Portion of Leases	3.17	3.11	0.11	0.02	0.54	0.85
Current Income Taxes Payable	0	0.21	7.45	7.22	5.4	-
Current Unearned Revenue	35.71	54.53	-	-	-	-
Other Current Liabilities	36.56	9.66	2.11	2.9	2.74	1.92
Total Current Liabilities	173.96	136.79	45.49	164.42	46.1	19.47
Long-Term Leases	3.96	4.79	0.19	-	-	0.61
Long-Term Unearned Revenue	52.67	35.59	-	-	-	-
Other Long-Term Liabilities	-	-0	-	6.79	12.8	-
Total Liabilities	230.59	177.17	45.68	171.21	58.9	20.08
Common Stock	0.92	0.92	0.92	0.51	0.51	0.26
Additional Paid-In Capital	1,298	1,298	1,298	503.52	503.69	276.74
Retained Earnings	-1,041	-952.8	-772	-606.84	-394.16	-145.08
Comprehensive Income & Other	23.71	23.53	28.67	26	16.84	-4.82
Shareholders' Equity	281.05	369.39	555.33	-76.8	126.87	127.1
Total Liabilities & Equity	511.64	546.56	601.01	94.41	185.77	147.18
Total Debt	52.93	7.9	0.3	131.03	0.54	1.46
Net Cash (Debt)	422.92	479.36	566.42	-43.06	173	136.75
Net Cash Growth	-19.21%	-15.37%	-	-	26.51%	-34.41%
Net Cash Per Share	9.10	10.29	15.29	-1.64	7.51	6.48
Filing Date Shares Outstanding	46.48	46.54	46.54	26.23	0.33	0.26
Total Common Shares Outstanding	46.48	46.54	46.54	26.23	0.33	0.26
Working Capital	328.83	400.06	554.97	-70.33	138.78	125.89
Book Value Per Share	6.05	7.94	11.93	-2.93	387.00	481.30
Tangible Book Value	281.05	369.39	555.33	-76.8	126.87	127.1
Tangible Book Value Per Share	6.05	7.94	11.93	-2.93	387.00	481.30

Source: S&P Global Market Intelligence. Standard template. Financial Sources.